This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Cellcentric Limited. Active years: 2022.
Company Filing History:
Years Active: 2022
Title: James Vaughan Morey: Innovator in Cancer Treatment
Introduction
James Vaughan Morey is a notable inventor based in Sudbury, GB. He has made significant contributions to the field of cancer treatment through his innovative research and development. His work focuses on creating modulators that can potentially improve therapeutic outcomes for various types of cancers.
Latest Patents
James Vaughan Morey holds a patent for a process aimed at preparing modulators of p300 and/or CBP. This patent describes a method for producing a compound that has shown promise in modulating p300/CBP activity. The process involves treating specific compounds to generate an intermediate compound, which is then further processed to recover the final compound. This compound has potential utility in treating several cancers, including prostate cancer, haematological cancers, bladder cancer, and lung cancer.
Career Highlights
Throughout his career, James has been associated with Cellcentric Limited, where he has been instrumental in advancing research related to cancer therapies. His innovative approach and dedication to improving treatment options have made him a valuable asset in the field.
Collaborations
James has collaborated with notable colleagues, including Paul Baguley and Donald Alan Gilbert. These partnerships have fostered a collaborative environment that enhances the research and development of new therapeutic strategies.
Conclusion
James Vaughan Morey is a distinguished inventor whose work in cancer treatment exemplifies innovation and dedication. His contributions through his patent and collaborations continue to pave the way for advancements in medical science.